Inivata
@InivataInivata is a leader in liquid biopsy. Our InVision® platform unlocks essential genomic information from a simple blood draw.
Similar User
@GenomicsEngland
@isliquidbiopsy
@Bicycle_tx
@NorthThamesGMS
@BabrahamUK
@PhoreMostLtd
@biopsy_liquid
@CI4CC
@Innovation_F
@tingfordha
@tony_biotech
@CellCentric
@VincentPlagnol
@timforshew
We are very pleased to announce that the US FDA has granted Breakthrough Device Designation for our #RaDaR #MRD #LiquidBiopsy assay Read more on our website: bit.ly/3quE4gD #MRD #Cancer
ICYMI #TeamInivata and collaborators presented ‘Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)’ at #ESMO22. View here: inivata.com/wp-content/upl… @myESMO #MRD #data
Come and meet #TeamInivata at this year’s 12th Annual World Clinical Biomarkers & #CDx Summit, taking place from 26-29 September. Find out more here: world-cdx.com #drugdevelopment #diagnostics #oncology
ICYMI #TeamInivata and collaborators presented a poster on ‘Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma’ at #ESMO22. View here: inivata.com/wp-content/upl… @myESMO #data #presentation
We will be attending the 12th Annual World Clinical Biomarkers & CDx Summit, taking place from 26-29 September in Boston. Our colleagues at @NeoGenomics will also be delivering a #presentation entitled ‘From Bench to Bedside: A CDx Odyssey’. world-cdx.com #event
#TeamInivata and its collaborators’ poster titled ‘Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO) won best poster in the session today at #ESMO22. @myESMO
Later today, #TeamInivata and collaborators will be presenting a poster, titled ‘Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)’ at 3-4pm CEST at #ESMO22. @myESMO
Don’t miss our RaDaR #data being shared on Sunday at #ESMO22. #TeamInivata and collaborators will be presenting a poster titled ‘Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma’ at 2-3pm CEST. @myESMO
The @myESMO congress kicks off tomorrow. For meetings, please contact Vishal Sikri, David Eberhard, Mike Nahorski, Huw Ricketts or Chris Pipinikas or get in touch at: inivata.com/about-us/conta… #ESMO22
Our CMO, David Eberhard, recently spoke with @GENBio about the challenges of detecting #MRD and how #liquidbiopsies can address these. Click below to read more about how we are working to transform care for cancer patients. bit.ly/3Bc9dgv #drugdevelopment #oncology
#TeamInivata, alongside its collaborators, will present new #data on our #RaDaR™ assay for the detection of #MRD and recurrence at the @myESMO Congress, taking place between 9-13 September 2022. Read more here: bit.ly/3RDLtsF #ESMO22
This September, Inivata is once again supporting #GynecologicCancerAwarenessMonth. Join us in highlighting the importance of bringing awareness to all gynecologic cancers. Get involved here: foundationforwomenscancer.org/events-courses…
The @myESMO Annual Meeting takes place next month. Members of #TeamInivata will be on the ground in Paris. For meetings, please contact Vishal Sikri, David Eberhard, Mike Nahorski, Huw Ricketts and Chris Pipinikas. esmo.org/meetings/esmo-… #ESMO22
Great to see in @ICR_London, alongside many other key stakeholders, supporting the use of biomarker testing to improve cancer patient diagnosis & care. Read more in this article from @thetimes: bit.ly/3p3fbuk #diagnostics #oncology #liquidbiopsy
At Inivata, our purpose is to help guide more informed #treatments for cancer patients. To hear the story of the first #patient tested with our InVisionFirst-Lung #liquidbiopsy test for #NSCLC, please see below. vimeo.com/699410987
ICYMI, we shared a poster presentation on “Plasma first: Accelerating lung #cancer diagnosis through liquid biopsy” at the 2022 ASCO® Annual Meeting. See here: inivata.com/wp-content/upl… #ASCO22
Today is #WorldLungCancerDay, a day focused on raising awareness of the challenges of #lungcancer - which accounts for nearly 1/5 cancer deaths globally. At Inivata, we show our support for all those impacted and remain committed to helping transform care for cancer #patients.
United States Trends
- 1. Bengals 80,8 B posts
- 2. Chargers 70,5 B posts
- 3. McPherson 12,4 B posts
- 4. Joe Burrow 22,1 B posts
- 5. Herbert 35,8 B posts
- 6. #BaddiesMidwest 22,2 B posts
- 7. #BoltUp 5.697 posts
- 8. Zac Taylor 4.443 posts
- 9. #ช็อตฟีลMV 177 B posts
- 10. MILKLOVE SHOT FEEL 228 B posts
- 11. #CINvsLAC 10,6 B posts
- 12. WWIII 183 B posts
- 13. #MondayMotivation 9.192 posts
- 14. 60 Minutes 33,9 B posts
- 15. Dobbins 8.805 posts
- 16. TAEYEON 38 B posts
- 17. Scotty 10,3 B posts
- 18. Harbaugh 16,4 B posts
- 19. Ladd McConkey 2.664 posts
- 20. Money Mac N/A
Who to follow
-
Genomics England
@GenomicsEngland -
International Society of Liquid Biopsy
@isliquidbiopsy -
Bicycle Therapeutics
@Bicycle_tx -
North Thames Genomic Medicine Service
@NorthThamesGMS -
Babraham Research Campus
@BabrahamUK -
PhoreMost
@PhoreMostLtd -
Liquid Biopsy
@biopsy_liquid -
Cancer Center Informatics Society
@CI4CC -
Innovation Forum
@Innovation_F -
Tina Han
@tingfordha -
Tony Jones
@tony_biotech -
CellCentric
@CellCentric -
Vincent
@VincentPlagnol -
Tim Forshew
@timforshew
Something went wrong.
Something went wrong.